Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
R-Pharm
Centre Leon Berard
University of Virginia
Catalysis SL
Celon Pharma SA
Federation of Italian Cooperative Oncology Groups
Icahn School of Medicine at Mount Sinai
Hangzhou Normal University
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Multitude Therapeutics Inc.
Philogen S.p.A.
Maastricht University Medical Center
Shanghai Henlius Biotech
Fudan University
Kineta Inc.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Shanghai Yunying Medical Technology
Fondazione del Piemonte per l'Oncologia
Synermore Biologics Co., Ltd.
Instituto do Cancer do Estado de São Paulo
Chang Gung Memorial Hospital
The First Affiliated Hospital of Xinxiang Medical College
Trans Tasman Radiation Oncology Group
Tanta University
Assiut University
Fudan University
Tarveda Therapeutics
Sichuan University
University Hospital, Strasbourg, France
Australasian Gastro-Intestinal Trials Group
Second Affiliated Hospital of Soochow University
Peking University
Blueprint Medicines Corporation
Blokhin's Russian Cancer Research Center
Consorzio Oncotech
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Jiangsu Cancer Institute & Hospital
Jiangsu Cancer Institute & Hospital
MercyOne Des Moines Medical Center
Peking University People's Hospital
MultiVir, Inc.
Peking University People's Hospital
Shanghai Chest Hospital
Radboud University Medical Center
Peking University People's Hospital
Evolve Biologics
Guangzhou Medical University
Sinocelltech Ltd.
First Hospital of Shijiazhuang City